Robert Bindert Huizinga - 10 Sep 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
EVP of Research
Signature
/s/ Robert Bindert Huizinga
Issuer symbol
AUPH
Transactions as of
10 Sep 2021
Net transactions value
-$687,325
Form type
4
Filing time
14 Sep 2021, 17:12:23 UTC
Previous filing
08 Sep 2021
Next filing
22 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale $99,150 -5,000 -3.6% $19.83 133,592 10 Sep 2021 Direct F1
transaction AUPH Common Stock Sale $98,800 -5,000 -3.7% $19.76 128,592 10 Sep 2021 Direct F1
transaction AUPH Common Stock Sale $489,375 -22,500 -17% $21.75 106,092 14 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.